Aktuelle News
News Funktionen
Weitere Funktionen
25 Mai 2015
EXINI Diagnostics AB
EXINI’s biomarker BSI for oral presentation at SNMMI
19 Mai 2015
EXINI Diagnostics AB
EXINI´s imaging biomarker BSI to be presented at ASCO
12 Mai 2015
EXINI Diagnostics AB
EXINI and Bone Scan Index (BSI) in two articles in important German Urology journal
27 April 2015
EXINI Diagnostics AB
EXINI: New upgrade agreement with FUJIFILM RI Pharma
20 April 2015
EXINI Diagnostics AB
EXINI and FUJIFILM RI Pharma in co-sponsored BSI-seminar in Tokyo
26 März 2015
EXINI Diagnostics AB
EXINI signs BSI-agreement with university hospital RWTH Aachen
4 März 2015
EXINI Diagnostics AB
EXINI appoints Henrik Perlmutter as Chairman of the Board
27 Januar 2015
EXINI Diagnostics AB
EXINI´s imaging biomarker BSI to be presented at important congress on prostate cancer
26 November 2014
EXINI Diagnostics AB
EXINI heart reaches 500 installations in Japan
19 November 2014
EXINI Diagnostics AB
EXINI enters collaboration with DexTech Medical
23 Oktober 2014
EXINI Diagnostics AB
EXINI and FUJIFILM RI Pharma’s symposium on BSI attracted attention at important European Congress
16 Oktober 2014
EXINI Diagnostics AB
EXINI to arrange Bone Scan Index (BSI) symposium at important annual European congress
22 September 2014
EXINI Diagnostics AB
EXINI: New BSI-results to be presented at cancer conference
8 September 2014
EXINI Diagnostics AB
EXINI’s heart-product fast growing on the Japanese market – hits 300 installed units
7 August 2014
EXINI Diagnostics AB
EXINI’s heart product hits 100 installations in Japan
24 Juni 2014
EXINI Diagnostics AB
EXINI: Bone Scan Index (BSI) as therapy-monitoring imaging biomarker, to be presented at the 2014 German Congress for Urology, DGU, in Düsseldorf
27 Mai 2014
EXINI Diagnostics AB
EXINI and FUJIFILM RI Pharma co-sponsors seminar on BSI and Imaging Biomarkers at the Sweden Life Science Summit in Tokyo
15 Mai 2014
EXINI Diagnostics AB
EXINI completes heart project for the Japanese market
8 Mai 2014
EXINI Diagnostics AB
EXINI: Benefits using BSI highlighted at the annual Japanese Urological Association’s meeting in Kobe, April 24-27, 2014
10 Februar 2014
EXINI Diagnostics AB
EXINI: Round table session focusing on imaging biomarkers at world congress
18 Dezember 2013
EXINI Diagnostics AB
EXINI launching a new website about the imaging biomarker Bone Scan Index
25 November 2013
EXINI Diagnostics AB
EXINI: Success for BSI at large congress on urological cancer
22 November 2013
EXINI Diagnostics AB
EXINI: Bonenavi 2.0 is now officially released
30 Oktober 2013
EXINI Diagnostics AB
EXINIs investment in imaging biomarkers attracted considerable interest at EANM (European Association of Nuclear Medicine)
3 Oktober 2013
EXINI Diagnostics AB
EXINI signs new commercial agreement with pharmaceutical company
27 August 2013
EXINI Diagnostics AB
EXINI signs new agreement with FUJIFILM RI Pharma
16 Mai 2013
EXINI Diagnostics AB
EXINI and Active Biotech present mutual results at US cancer conference
30 Oktober 2012
EXINI Diagnostics AB
EXINI and Active Biotech initiate collaboration, aiming to clinically evaluate the future of cancer treatment.
7 September 2012
EXINI Diagnostics AB
EXINI: Focus on opportunities with BSI at the ‘Bone Scan Index meeting’ in Malmö
20 August 2012
EXINI Diagnostics AB
Breakthrough for EXINI, FDA approval for EXINI bone™.